Key facts
- Ophelia (Clinics/Outpatient Services)’s last known valuation is $275.0M (Dec 2021).
- It has raised $68.5M; the latest was Later Stage VC in Mar 2025.
- Notable investors include Y Combinator, General Catalyst, Impact Assets, Tiger Global Management, Menlo Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Ophelia (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for Ophelia (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ophelia (Clinics/Outpatient Services)
Developer of a digital medication-assisted treatment (MAT) platform designed to make evidence-based treatment universally accessible. The company's software platform includes organizing teleconferenced doctor visits, prescribing and delivering medications, offering access to therapy without the stigma, enabling opioid addicts to have treatment from the comfort of their homes, and providing MAT-licensed clinicians with infrastructure, training, and support to treat patients.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2018
- Employees
- 190
- Website
- ophelia.com/
- Ownership
- Privately Held (backing)
Ophelia (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ophelia (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ophelia (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.